|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2.260 USD | +3.20% |
|
-4.24% | +38.65% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
| Market Cap | 428M 381M 354M 322M 607M 40.65B 618M 4.25B 1.66B 21.14B 1.6B 1.57B 67.61B | P/E 2026 * |
-5.91x | P/E 2027 * | -5.58x |
|---|---|---|---|---|---|
| Enterprise Value | 301M 268M 249M 227M 427M 28.58B 434M 2.99B 1.17B 14.86B 1.13B 1.1B 47.53B | EV / Sales 2026 * |
376x | EV / Sales 2027 * | 519x |
| Free-Float |
93.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OVID | Delayed | |
CBOE
| OVID | Real-time | |
|
Deutsche Boerse AG
| 1OT | Delayed | |
|
Börse Stuttgart
| 1OT | Delayed | |
|
Boerse Muenchen
| 1OT | Real-time | |
|
Tradegate
| 1OT | Real-time |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | +3.20% | ||
| 1 week | -4.24% | ||
| Current month | -9.24% | ||
| 1 month | -17.52% | ||
| 3 months | -8.13% | ||
| 6 months | -23.65% | ||
| Current year | +38.65% |
| 1 week | 2.09 |  | 2.49 |
| 1 month | 2.09 | | 2.84 |
| Current year | 1.36 | | 3.1 |
| 1 year | 1.18 | | 3.1 |
| 3 years | 0.24 | | 4.1 |
| 5 years | 0.24 | | 4.14 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2025-12-31 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 2026-07-05 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 2025-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 2014-03-31 |
Bart Friedman
BRD | Director/Board Member | 81 | 2015-11-22 |
Barbara Duncan
BRD | Director/Board Member | 61 | 2017-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/6/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 7/6/26 | Other | Chief Financial Officer | 450,625 | 0.2414% | ||
| 4/7/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -4.24% | +29.14% | -38.42% | 428M | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | -9.54% | +10.39% | +60.04% | 51.9B | |
| +3.14% | +4.61% | +15.36% | +44.42% | 48.73B | |
| +3.45% | +5.01% | +32.37% | +35.96% | 43.13B | |
| -2.20% | -5.78% | +298.44% | +532.76% | 41.48B | |
| +6.43% | +2.76% | +16.56% | +109.23% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +1.74% | -5.30% | -12.09% | -12.92% | 22.27B | |
| Average | +1.67% | -4.23% | +50.42% | +84.66% | 37.34B | |
| Weighted average by Cap. | +1.58% | -3.49% | +56.54% | +105.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 799K 713K 661K 602K 1.13M 75.96M 1.15M 7.94M 3.11M 39.51M 3M 2.94M 126M | 186K 166K 154K 140K 264K 17.69M 269K 1.85M 724K 9.2M 698K 683K 29.41M |
| Net income | -68.57M -61.15M -56.72M -51.67M -97.3M -6.52B -99.07M -681M -267M -3.39B -257M -252M -10.84B | -84.06M -74.96M -69.53M -63.34M -119M -7.99B -121M -835M -327M -4.16B -315M -309M -13.29B |
| Net Debt | -127M -113M -105M -95.69M -180M -12.07B -183M -1.26B -494M -6.28B -476M -466M -20.08B | -331M -295M -274M -250M -470M -31.48B -478M -3.29B -1.29B -16.37B -1.24B -1.22B -52.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | US$2.260 | +3.20% | 1,329,988 |
| 26-10-14 | US$2.190 | 0.00% | 1,642,457 |
| 26-10-13 | US$2.190 | -9.13% | 1,642,723 |
| 26-10-12 | US$2.410 | -2.03% | 876,042 |
| 26-10-09 | US$2.460 | +5.13% | 1,406,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
